Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
about
Optimized imaging of the midface and orbitsBiologic imaging of head and neck cancer: the present and the futurePrognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumorsLimited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma.Restricting carbohydrates to fight head and neck cancer-is this realistic?Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapyDiffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoringThe role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.FDG-PET/CT pitfalls in oncological head and neck imaging.Precision Medicine and PET/Computed Tomography: Challenges and Implementation.No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.Post-treatment appearances, pitfalls, and patterns of failure in head and neck cancer on FDG PET/CT imaging.PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.Diagnostic performance of 18 fluorodesoxyglucose positron emission/computed tomography and magnetic resonance imaging in detecting T1-T2 head and neck squamous cell carcinoma.Contribution of 18F-FDG PET/CT to Staging of Head and Neck Malignancies.
P2860
Q26771867-8D45B3BE-D66A-460B-9C44-6DAFF5DB3B59Q27023296-45A83EE4-55D0-4EE3-8BC0-58B225E085C0Q33704148-9A94F76F-719B-4EDC-BD8A-8992C3B5EC83Q33792289-CDD36346-8D55-4673-9503-FAF8DCEC78E8Q33819012-986B4A82-73D9-459C-8FCA-E1A6747A8B79Q34127555-7D5FC3EA-4EF4-46BE-BB3C-AAA1164E108EQ34340949-62BEE216-56A4-4B41-B083-B2D73E44C0CCQ35178830-6D8B4AC6-28B5-45FB-A272-153D385DC1CEQ35789209-8F419C86-82BC-4F1D-B911-06DD53FB2E22Q35840022-99E0A8FD-FB32-4A48-A09A-4BE0A6F36FDAQ36529838-7DBB1A95-1C73-4003-BEEB-9F9218773256Q36906195-0BD303E3-2B57-4336-BA59-0F4DE9D3D9B8Q36915894-F173B32C-6357-485A-AE84-59DAF787D6E6Q38000079-FEB1C8EA-6846-436A-8ED9-E8B4EDEE2F12Q38243007-399DA6DD-552F-4E74-901A-90C744066D14Q39013336-8E09B85A-A5B0-4859-9236-83F55BF3A573Q41683201-3DF2C30F-8B90-42BA-BFC1-0055ACE1E73FQ41743777-330F5990-FE87-4AD6-A715-C4BA9ACFD284Q42436588-E3C7061F-0CDD-4A07-A618-981033062CA1Q45371931-6C395A1E-E15C-4862-B22F-351F81E18572Q47297629-509A76B4-75C3-4C4E-A443-6D8B7E59095FQ48296713-8A75A74A-CEF6-4D5C-A26E-AC8FE546A095Q49382278-640B2E0D-6B33-4877-9BFF-F775294E3C18
P2860
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@ast
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@en
type
label
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@ast
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@en
prefLabel
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@ast
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@en
P2093
P2860
P356
P1476
Fluorodeoxyglucose-positron-em ...... and neck squamous cell cancer.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A1760
P577
2009-11-12T00:00:00Z